```html

Quincke’s Disease (Angioedema) – A Comprehensive Medical Guide

Overview

Quincke’s disease, more commonly referred to as angioedema, is a rapid swelling of the deeper layers of the skin and mucous membranes. The swelling typically involves the lips, eyes, tongue, throat, and sometimes the genitals or extremities. Unlike ordinary hives (urticaria), which are superficial and itchy, angioedema affects the deeper dermis and subcutaneous tissue and can be painful rather than itchy.

Although it can occur at any age, the condition is most frequently diagnosed in adults between 20 and 40 years old. Epidemiologic data suggest that 1–5 % of the general population will experience an episode of angioedema at some point in their lives (Mayo Clinic, 2023). Women are slightly more often affected than men, especially when the cause is drug‑related (e.g., ACE‑inhibitor–induced angioedema).

There are three major categories:

• Allergic (histamine‑mediated) angioedema – triggered by foods, insect stings, or medications.
• Bradykinin‑mediated angioedema – hereditary (HAE) or acquired (often ACE‑inhibitor related).
• Idiopathic – no identifiable trigger after thorough evaluation.

Symptoms

Symptoms can appear abruptly and evolve over minutes to several hours. The clinical picture varies according to the type and location of swelling.

• Localized swelling – non‑pitting, warm, and firm; commonly affects lips, eyelids, tongue, floor of mouth, and airway structures.
• Facial edema – puffiness of the cheeks, periorbital area, or entire face.
• Oral involvement – swollen lips, tongue, or palate that may interfere with speech and eating.
• Airway compromise – sensation of “tightness” in the throat, difficulty swallowing (dysphagia), hoarseness, or stridor.
• Gastrointestinal symptoms – abdominal pain, nausea, vomiting, or diarrhea can occur when swelling involves the bowel wall (particularly in hereditary angioedema).
• Skin changes – unlike urticaria, lesions are usually not itchy and do not leave a wheal.
• Systemic signs – in severe cases, hypotension, tachycardia, or syncope may develop secondary to airway obstruction or massive fluid shift.

Causes and Risk Factors

Allergic (Histamine‑Mediated) Angioedema

• Foods: shellfish, nuts, eggs, strawberries, and other allergens.
• Medications: antibiotics (especially penicillins, sulfonamides), non‑steroidal anti‑inflammatory drugs (NSAIDs), and vaccines.
• Insect stings: bees, wasps, ants.
• Latex or other contact allergens.

Bradykinin‑Mediated Angioedema

• Hereditary Angioedema (HAE): Mutations in the C1‑INH (SERPING1) gene leading to deficient or dysfunctional C1‑esterase inhibitor. Autosomal dominant; prevalence ≈ 1 in 50,000–100,000 (World Allergy Organization, 2022).
• Acquired C1‑INH deficiency: Often associated with lymphoproliferative disorders or autoimmune disease.
• ACE‑inhibitor therapy: Angiotensin‑converting‑enzyme inhibitors block bradykinin breakdown, precipitating swelling in 0.1–0.7 % of users (CDC, 2023).

Idiopathic

When no trigger is identified after detailed history, labs, and imaging, the condition is labeled idiopathic. This accounts for ~30 % of adult angioedema cases (Cleveland Clinic, 2024).

Risk Factors

• Family history of hereditary angioedema.
• Use of ACE inhibitors, especially in African‑American patients (higher incidence).
• Previous episodes of angioedema.
• Concurrent autoimmune diseases (e.g., lupus).
• Pregnancy – can exacerbate hereditary forms.

Diagnosis

Diagnosing angioedema begins with a thorough clinical history and physical examination, focused on identifying triggers, pattern of attacks, and airway risk.

Key Diagnostic Steps

1. History taking – onset, duration, location of swelling, associated symptoms, medication list, recent infections, and family history.
2. Physical exam – assess depth of edema, look for urticaria, check airway patency, and examine oral cavity.
3. Laboratory tests –
   • Complete blood count (CBC) & differential – to rule out infection.
   • Serum complement levels (C4, C1‑esterase inhibitor antigenic and functional levels) – low C4 and low/low‑function C1‑INH suggest hereditary or acquired C1‑INH deficiency.
   • Tryptase level – elevated in mast‑cell mediated (allergic) reactions.
4. Allergy testing – skin prick or specific IgE testing when an allergic trigger is suspected.
5. Imaging (if airway involvement) – Lateral neck X‑ray or CT scan to evaluate supraglottic edema.
6. Genetic testing – for confirmed or suspected hereditary angioedema (SERPING1 mutation analysis).

Diagnostic Criteria for Hereditary Angioedema

According to the International HAE Working Group (2021), a diagnosis requires:

• Recurrent, unexplained subcutaneous or submucosal swelling episodes, and
• Reduced functional C1‑INH activity (< 50 % of normal) or documented SERPING1 mutation.

Treatment Options

Treatment is tailored to the underlying mechanism (histamine vs. bradykinin) and the severity of the episode.

Acute Management

• Airway protection – If there is any sign of airway compromise, call emergency services immediately. Endotracheal intubation or surgical airway (cricothyrotomy) may be required.
• Histamine‑mediated angioedema:
  • Epinephrine 0.3 mg intramuscular (IM) – repeat every 5–15 min if symptoms persist.
  • Antihistamines – diphenhydramine 25–50 mg PO/IV, cetirizine 10 mg PO.
  • Corticosteroids – prednisone 40–60 mg PO or methylprednisolone 125 mg IV.
• Bradykinin‑mediated angioedema (e.g., HAE or ACE‑inhibitor related):
  • C1‑esterase inhibitor concentrate (Berinert®, Cinryze®) – 20 U/kg IV.
  • Bradykinin receptor antagonist (Icatibant, Firazyr®) – 30 mg subcutaneously, may repeat after 6 hours.
  • Recombinant C1‑INH (Ruconest®) – 50 U/kg IV.

  Note: Conventional antihistamines, steroids, and epinephrine are generally ineffective for bradykinin‑mediated attacks.

Long‑Term Management

• Avoidance of known triggers – read medication labels, discuss alternatives with your prescriber.
• Prophylactic medications:
  • For hereditary angioedema:
    • Androgens (danazol 50–200 mg daily) – effective but monitor liver function.
    • Antifibrinolytics (tranexamic acid 1–1.5 g PO q6h) – modest benefit.
    • Regular C1‑INH replacement therapy (IV or subcutaneous) for high‑frequency patients.
  • For ACE‑inhibitor–induced angioedema: discontinue the ACE inhibitor and switch to an angiotensin‑II receptor blocker (ARB) only after evaluation.
• Patient‑controlled rescue therapy – Many HAE patients are prescribed on‑demand icatibant or C1‑INH concentrate to self‑administer at the first sign of an attack.
• Lifestyle modifications – Adequate hydration, stress‑reduction techniques, and avoidance of known physical triggers (e.g., trauma, dental procedures).

Consultation & Follow‑up

Patients with recurrent or unexplained episodes should be referred to an allergist/immunologist or a clinical immunology specialist. Regular follow‑up (every 3–6 months) enables monitoring of attack frequency, side‑effects of prophylaxis, and adjustment of therapy.

Living with Quincke’s Disease (Angioedema)

Managing a chronic condition requires practical daily strategies.

• Carry an emergency kit – Include a pre‑filled epinephrine auto‑injector (if allergic type), antihistamines, a copy of your prescription for on‑demand C1‑INH or icatibant, and a written action plan.
• Medical alert identification – Wear a bracelet or necklace indicating “Angioedema – may affect airway” and list current medications.
• Educate close contacts – Family, friends, and coworkers should know how to recognize severe swelling and how to administer emergency medication.
• Track attacks – Use a diary or mobile app to record date, time, possible trigger, severity, and treatment response. This information aids clinicians in tailoring therapy.
• Dental and surgical precautions – Inform dentists and surgeons of your condition; prophylactic C1‑INH may be needed before procedures that manipulate oral mucosa.
• Stress management – Stress can precipitate attacks in hereditary forms. Techniques such as mindfulness, yoga, or counseling are beneficial.
• Vaccinations – Generally safe; however, discuss with your allergist if you have a history of vaccine‑related angioedema.

Prevention

1. Medication review – Ask your physician to evaluate the necessity of ACE inhibitors or NSAIDs if you have a prior episode.
2. Allergen avoidance – Conduct formal allergy testing and adhere to strict avoidance of confirmed food or insect allergens.
3. Prophylactic therapy adherence – Take prescribed prophylactic agents exactly as directed; missing doses can increase attack frequency.
4. Vaccinate against hepatitis B and C – Reduces risk of acquired C1‑INH deficiency linked with chronic liver disease.
5. Prompt treatment of infections – Upper respiratory infections can trigger attacks, especially in hereditary angioedema.

Complications

When left untreated or inadequately managed, angioedema can lead to serious outcomes:

• Airway obstruction – The most life‑threatening complication; can result in hypoxia, cardiac arrest, or death.
• Permanent disfigurement – Repeated facial swelling may stretch skin, causing cosmetic concerns.
• Psychological impact – Anxiety, depression, and reduced quality of life are common, especially in patients with unpredictable attacks.
• Medication side‑effects – Long‑term androgen prophylaxis can cause liver toxicity, lipid abnormalities, and virilization in women.
• Secondary infections – Persistent oral or facial edema can become a nidus for bacterial infection if hygiene is compromised.

When to Seek Emergency Care

---

**References**

1. Mayo Clinic. “Angioedema.” Updated 2023. https://www.mayoclinic.org
2. Centers for Disease Control and Prevention. “ACE Inhibitor‑Associated Angioedema.” 2023. https://www.cdc.gov
3. National Institutes of Health, National Institute of Allergy and Infectious Diseases. “Hereditary Angioedema.” 2022. https://www.niaid.nih.gov
4. World Allergy Organization. “Guidelines for the Management of Hereditary Angioedema.” 2022. https://www.worldallergy.org
5. Cleveland Clinic. “Angioedema: Symptoms, Causes, and Treatment.” 2024. https://my.clevelandclinic.org
6. International HAE Working Group. “Diagnostic Criteria for Hereditary Angioedema.” 2021. https://www.angioedema.org

```